At a glance
ClinicalIndex Comparison RecordN/ACompleted· 14 enrolled
Drug / intervention
Morning bright light therapy +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Feasibility of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors
In Brief
A clinical study evaluating Morning bright light therapy and Dim light for Fatigue and 2 related conditions. Completed, enrolled 14 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the feasibility of a morning bright light therapy intervention for fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFatigue, Sleep Disturbance, Circadian Dysregulation
CountriesUnited States
CollaboratorsOncology Nursing Society
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartOct 2016
First PostedNov 2016
Primary CompletionJan 2018
TodayJul 2026
First PostedNov 3, 2016
Enrollment StartOct 1, 2016
Primary CompletionJan 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 9.7 years ago
Interventions
Morning bright light therapydevice
Exposure to morning bright light therapy delivered with Green-Blue Re-Timer glasses for 30 minutes in the morning during one week.
Dim lightdevice
Exposure to dim light with Red-Yellow Re-Timer glasses for 30 minutes in the morning during one week.